Maravai Lifesciences Holdings (MRVI) Accounts Payables (2020 - 2026)

Maravai Lifesciences Holdings' Accounts Payables history runs 7 years deep, the most recent figure standing at $8.5 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 10.39% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (down 10.39% YoY), while the FY2025 annual figure was $2.9 million, down 75.66% from the prior year.
• Accounts Payables was $8.5 million for Q1 2026 at Maravai Lifesciences Holdings, up from $2.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $678.4 million in Q3 2023 to a low of $2.9 million in Q4 2025.
• Historically, Accounts Payables has averaged $94.5 million across 5 years, with a median of $9.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables surged 7072.01% in 2023, then slumped 98.6% in 2024.
• A 5-year view of Accounts Payables shows it stood at $42.3 million in 2022, then slumped by 83.27% to $7.1 million in 2023, then jumped by 69.15% to $12.0 million in 2024, then slumped by 75.66% to $2.9 million in 2025, then soared by 193.3% to $8.5 million in 2026.
• The last three Accounts Payables figures came in at $8.5 million (Q1 2026), $2.9 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.